No, major health insurance plans and Medicare do not pay for or cover stem cell therapy for orthopedic or chronic conditions in Denver.
That is the honest answer, and you deserve it before you spend an afternoon on hold with your carrier.
Why Plans Exclude It
Insurers do not decide coverage case by case. Each carrier publishes a medical policy for a treatment category, and the claim is paid or denied against that policy.
For orthopedic stem cell therapy, the published policies land in the same place. Aetna’s policy on knee osteoarthritis describes stem cell therapy as experimental and investigational because effectiveness has not been established. Cigna’s orthopedic stem cell policy reaches the same conclusion across indications. Platelet-rich plasma is treated the same way by the major commercial carriers for musculoskeletal use.
Medicare does not cover platelet-rich plasma or cell-based injections for osteoarthritis either. The narrow exception in Medicare’s PRP coverage relates to chronic non-healing diabetic wounds, not joints.
Behind those policies sits a regulatory fact worth knowing: there is no FDA-approved stem cell product for any orthopedic condition. Autologous procedures, meaning procedures using your own bone marrow or fat, are performed under a different part of the framework than approved drugs and biologics. If you want the detail, we wrote about how the FDA regulates this field. Payers lean heavily on that distinction.
Anyone telling you the injection is FDA-approved, or that they can get it covered, is telling you something the published policies do not support.
What Usually Is Covered
This is the part most articles skip, and it can save you real money.

The regenerative injection is one line item. The care around it often runs through your plan ordinarily:
- The diagnosis. Office visits, X-rays, and MRI ordered to work out what is actually wrong with the joint are billed to your insurance like any other orthopedic workup.
- Conventional treatment you may have already tried. Physical therapy, cortisone injections, and hyaluronic acid injections are generally covered when your plan’s criteria are met.
- Lab work tied to a covered diagnosis. Coverage depends on the ordering reason and your plan’s rules.
So the practical picture for most patients is a covered diagnostic path and a self-pay procedure. Ask your carrier about each piece separately rather than asking one broad question about “stem cells,” which will get you a fast no.
HSA, FSA and Superbills
Health savings and flexible spending accounts are where most of our patients find real leverage.
Under the tax code, a qualified medical expense is an amount paid for the diagnosis, cure, mitigation, treatment or prevention of disease, or for the purpose of affecting a structure or function of the body. A physician-directed injection for a diagnosed joint condition is a different kind of expense from an elective cosmetic procedure, and many plan administrators treat it accordingly.
Two things to do before you assume:
- Ask your plan administrator in writing whether the specific procedure code qualifies. Administrators differ, and the answer you get in writing is the one that protects you.
- Ask us for a superbill. A superbill is an itemized receipt with diagnosis and procedure codes. It is what your administrator will want to see, and it is also what you would submit if you chose to try for out-of-network reimbursement.
A superbill is not a promise of reimbursement. It is documentation. Submitting one to a plan that excludes the category will not change the exclusion.
What About Financing?
Financing is available, and it is common in this category, because these are cash-pay procedures. We can walk you through the options during your consultation, including what a monthly figure actually looks like for the treatment you are considering.
We would rather you understand the full cost before you commit than discover it later. If you want to see the cost picture first, start with what stem cell therapy costs in Denver.
The Questions Worth Asking Before You Pay
If you are weighing a self-pay procedure, coverage is only the first question. These matter more:
- Am I a candidate? Some joints and some stages of arthritis respond better than others. We will tell you if we do not think you are a good candidate. That conversation is free, and it is the point of checking candidacy before anything else.
- Who performs the procedure? Ask for the name and the credentials. At our clinic, harvest and injection procedures are performed under the oversight of Dr. Andrew Hong, MD.
- What imaging guidance is used, and for which joint? Guidance requirements differ between a superficial tendon and a deep hip joint.
- What happens if it does not help? Ask directly what the follow-up plan is.
- What is the total, all in? Harvest, processing, injection, imaging, follow-up visits.
The Colorado Piece
Coverage is set by your plan’s medical policy, not by your zip code, so a Denver patient and a Fort Collins patient with the same carrier and the same plan get the same answer. What does change locally is what you are weighing the cost against. A Front Range patient thinking about a spring on the knee, the hip, or the shoulder is usually comparing this against a surgical timeline that costs a season.
That comparison is yours to make. Our job is to give you accurate inputs.
If you are asking the same question about hormone therapy, the answer differs by service, and we covered it separately in TRT and insurance.
Talk to Us Before You Talk to Your Carrier
Bring your imaging, your diagnosis, and your questions. We will tell you honestly whether you are a candidate, what the procedure would involve, and exactly what it would cost, with no coverage guesswork in either direction.
Schedule your free consultation today.
This article is general information about insurance and payment practices and is not medical, tax, or legal advice. Coverage depends on your specific plan documents, your carrier’s current medical policy, and your diagnosis. Verify benefits with your carrier and eligibility with your plan administrator before treatment.
Frequently Asked Questions
Will my insurance pay for stem cell therapy in Denver?
Generally no, not for the injection itself. Major commercial carriers including Aetna and Cigna classify orthopedic stem cell therapy as experimental and investigational in their published medical policies, which means it is excluded from coverage. Platelet-rich plasma is treated the same way for musculoskeletal conditions. Coverage depends on your specific plan documents, so confirm with your carrier.
Does Medicare cover stem cell therapy for knees or hips?
Medicare does not cover platelet-rich plasma or cell-based injections for osteoarthritis. Medicare’s narrow PRP coverage applies to chronic non-healing diabetic wounds under specific conditions, not to joint injections.
Can I use my HSA or FSA for stem cell therapy?
Many patients do. A qualified medical expense under the tax code is an amount paid for the diagnosis, treatment, or mitigation of disease, or for affecting a structure or function of the body. Whether a specific procedure qualifies is determined by your plan administrator, so ask in writing before you pay, and ask the clinic for an itemized superbill with diagnosis and procedure codes.
Is any part of the visit covered?
Often yes. Office visits, X-rays, MRI and conventional treatments such as physical therapy or cortisone injections are typically billed to insurance in the ordinary way when your plan’s criteria are met. It is the regenerative injection itself that is usually self-pay. Ask your carrier about each item separately.
What is a superbill and will it get me reimbursed?
A superbill is an itemized receipt listing diagnosis and procedure codes. It is the documentation an HSA or FSA administrator will ask for, and it is what you would submit if you attempted out-of-network reimbursement. It is documentation, not a guarantee of payment, and it will not override a plan exclusion.
Why is stem cell therapy not covered when the clinic says it works?
Coverage decisions follow published payer medical policies, which currently classify these injections as investigational for orthopedic use. There is also no FDA-approved stem cell product for any orthopedic condition. Patient experience and payer policy are two different standards, and it is fair to ask any clinic to explain both honestly.
Should I appeal a denial?
You can appeal, and the appeal rights are in your plan documents. When a denial is based on a categorical exclusion rather than a medical necessity judgment, appeals are less likely to succeed. Ask your carrier in writing whether the denial is based on an exclusion or on medical necessity, because that determines whether an appeal is worth your time.


Can Stem Cells Cure Multiple Myeloma?